Magenta Therapeutics (NASDAQ:MGTA) reported quarterly losses of $(0.29) per share. This is a 9.38 percent increase over losses of $(0.32) per share from the same period last year.
JP Morgan Maintains Underweight on Acadia Realty Trust, Lowers Price Target to $16
JP Morgan analyst Michael Mueller maintains Acadia Realty Trust (NYSE:AKR) with a Underweight and lowers the price target from $19 to $16.